MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 219 filers reported holding MOMENTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $12,964,000 | +48.3% | 247,019 | -6.0% | 0.01% | +33.3% |
| Q2 2020 | $8,742,000 | +43.8% | 262,751 | +17.5% | 0.01% | +28.6% |
| Q1 2020 | $6,081,000 | +34.2% | 223,558 | -2.6% | 0.01% | +75.0% |
| Q4 2019 | $4,531,000 | +71.7% | 229,629 | +12.8% | 0.00% | +33.3% |
| Q3 2019 | $2,639,000 | +25.2% | 203,629 | +20.2% | 0.00% | +50.0% |
| Q2 2019 | $2,108,000 | -14.7% | 169,341 | -0.4% | 0.00% | -33.3% |
| Q1 2019 | $2,471,000 | +78.7% | 170,046 | +35.8% | 0.00% | +50.0% |
| Q4 2018 | $1,383,000 | -54.2% | 125,246 | +9.1% | 0.00% | -50.0% |
| Q3 2018 | $3,020,000 | +22.0% | 114,846 | -5.1% | 0.00% | +33.3% |
| Q2 2018 | $2,476,000 | +4.8% | 121,063 | -7.0% | 0.00% | 0.0% |
| Q1 2018 | $2,363,000 | +24.2% | 130,200 | -4.5% | 0.00% | 0.0% |
| Q4 2017 | $1,903,000 | -22.8% | 136,400 | +2.4% | 0.00% | -25.0% |
| Q3 2017 | $2,464,000 | +9.5% | 133,200 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $2,251,000 | +29.4% | 133,200 | +2.2% | 0.00% | +33.3% |
| Q1 2017 | $1,740,000 | -15.0% | 130,300 | -4.2% | 0.00% | 0.0% |
| Q4 2016 | $2,047,000 | +22.4% | 136,000 | -4.9% | 0.00% | 0.0% |
| Q3 2016 | $1,672,000 | +1.3% | 143,000 | -6.5% | 0.00% | 0.0% |
| Q2 2016 | $1,651,000 | +13.3% | 152,900 | -3.0% | 0.00% | +50.0% |
| Q1 2016 | $1,457,000 | -51.1% | 157,700 | -21.4% | 0.00% | -60.0% |
| Q4 2015 | $2,977,000 | -7.0% | 200,600 | +2.9% | 0.01% | 0.0% |
| Q3 2015 | $3,200,000 | -26.0% | 195,000 | +2.9% | 0.01% | -16.7% |
| Q2 2015 | $4,322,000 | +240.6% | 189,500 | +61.6% | 0.01% | +200.0% |
| Q1 2015 | $1,269,000 | 0.0% | 117,300 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,269,000 | -4.6% | 117,300 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,330,000 | -6.1% | 117,300 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,417,000 | +9.5% | 117,300 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $1,294,000 | -37.5% | 117,300 | 0.0% | 0.00% | -33.3% |
| Q4 2013 | $2,070,000 | +20.6% | 117,300 | -1.7% | 0.00% | 0.0% |
| Q3 2013 | $1,717,000 | +12.4% | 119,292 | +17.7% | 0.00% | 0.0% |
| Q2 2013 | $1,527,000 | – | 101,392 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,790,400 | $55,055,000 | 4.79% |
| Camber Capital Management LP | 3,250,000 | $64,123,000 | 3.26% |
| Avidity Partners Management LP | 200,000 | $3,946,000 | 2.49% |
| Asymmetry Capital Management, L.P. | 62,585 | $1,235,000 | 2.21% |
| Palo Alto Investors LP | 1,685,372 | $33,252,000 | 1.83% |
| Monashee Investment Management LLC | 90,223 | $1,780,000 | 1.66% |
| Greencape Capital Pty Ltd | 217,078 | $4,283,000 | 1.65% |
| Redmile Group, LLC | 3,237,700 | $63,880,000 | 1.53% |
| Ghost Tree Capital, LLC | 400,000 | $7,892,000 | 1.50% |
| Perceptive Advisors | 2,835,637 | $55,947,000 | 1.11% |